- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07287566
Impact of Oral Care on Ventilator Associated Pneumonia (OH-VAP)
The Impact of Different Methods of Oral Hygiene on Incidence of Ventilator Associated Pneumonia in Pediatric Intensive Care Unit
The goal of this clinical trial was to find out whether cleaning the mouths of children in the Pediatric Intensive Care Unit (PICU) with toothbrushing and chlorhexidine lowers the chance of getting lung infections in patients on breathing machines compared to routine mouth care. The study determined whether this approach changed how long children need a breathing machine, how many days they stayed in the PICU, and whether it affects survival. The main questions it aimed to answer were:
- Did toothbrushing with chlorhexidine, compared to routine mouth care, lowered the risk of lung infections in patients on breathing machines in the PICU?
- Did this approach also affect recovery outcomes, including duration of needing a breathing machine, length of PICU stay, and survival rates?
Researchers compared toothbrushing and chlorhexidine to routine mouth care to see if toothbrushing and chlorhexidine lowered the risk of lung infections in patients on breathing machines.
Participants:
Had safety practices to prevent lung infections in patients on breathing machines Had toothbrushing and chlorhexidine or routine mouth care three times daily 5 minutes in each Had physical check-up and any tests needed as part of their care
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pediatric dentist trained the nurses to follow the proper oral care protocol. Safe practices as keeping the patient's head slightly raised while lying in bed and clean the patients mouth regularly to remove germs. Participants and researcher didn't know which oral care method was being administered making this double blinded study. The participants were divided into two groups 59 patients in each group. In Tooth brushing group, tooth paste and soft tooth brush was positioned at 45 degree angle with a firm gentle pressure, brushing back and forth or using a circular motion 15 to 20 times before moving to the next area for one minute plus application of chlorhexidine mouthwash to a swab on the oral mucosa, teeth, gums, hard palate, and tongue, followed by 20 milliliter (mL) of normal saline, the procedure was finished with hypo pharyngeal suctioning. In routine oral care group only a swab with chlorhexidine and rubbing it on the surface of the tongue, gum and mucosa followed by 20 mL of normal saline, the procedure was finished with hypo pharyngeal suctioning.
investigations include laboratory (Complete blood picture, C-reactive protein and Venous blood gases (VBG) were done. Radiological and microbiological included sputum culture collected on fifth day were also done.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt, 00002
- Pediatric Intensive Care Units, Children Hospital, Ain shams university
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria: dentate mechanically ventilated
-
Exclusion Criteria:
- primary immune deficiency coagulation disorders jaw fractures
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: intervention group
Toothbrushing + Chlorohexidine
|
three times daily for 5 minutes
|
|
Active Comparator: control group
Routine oral care + Chlorohexidine
|
three times daily for 5 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
incidence of VAP in pediatric patients in PICU receiving toothbrushing and chlorohexidine in comparison to routine oral hygiene
Time Frame: Baseline, Day 2, Day3, Day 4 and Day 5 of enrollment
|
number of patients who develop VAP
|
Baseline, Day 2, Day3, Day 4 and Day 5 of enrollment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ahmed R. Ahmed, MD, Ain Shams University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Healthcare-Associated Pneumonia
- Pathologic Processes
- Disease Attributes
- Respiratory Tract Infections
- Infections
- Respiratory Tract Diseases
- Lung Diseases
- Pneumonia
- Cross Infection
- Iatrogenic Disease
- Pathological Conditions, Signs and Symptoms
- Pneumonia, Ventilator-Associated
- Organic Chemicals
- Biguanides
- Guanidines
- Amidines
- Dentistry
- Preventive Dentistry
- Oral Hygiene
- Chlorhexidine
- Toothbrushing
Other Study ID Numbers
- FMASU MS407 /2024
- FMA MS407 /2024 (Other Identifier: Research Ethics Committee-Faculty of Medicine-ASU)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventilator Associated Pneumonia ( VAP)
-
Ain Shams UniversityCompletedSepsis | Ventilator Associated Pneumonia ( VAP)Egypt
-
Centre Hospitalier Universitaire de NīmesNot yet recruiting
-
Chinese PLA General HospitalPeking University Third Hospital; The First Affiliated Hospital of Zhengzhou... and other collaboratorsNot yet recruitingBacteriophage Cocktail Therapy for Multidrug-Resistant Gram-Negative Ventilator-Associated PneumoniaVAP - Ventilator Associated Pneumonia
-
Esraa Salah Mohamed Abdallah EladlEnrolling by invitationVentilator-Associated Pneumonia (VAP)Egypt
-
Postgraduate Medical Institute, LahoreCompletedVentilator Associated Pneumonia ( VAP)Pakistan
-
Marmara UniversityActive, not recruitingVentilator Associated Pneumonia ( VAP)Turkey (Türkiye)
-
Erasmus Medical CenterChiesi Farmaceutici S.p.A.CompletedVentilator Associated Pneumonia (VAP)Spain, Netherlands
-
Andrzej Frycz Modrzewski Krakow UniversityCompletedVAP - Ventilator Associated PneumoniaPoland
-
Assiut UniversityNot yet recruitingVAP - Ventilator Associated Pneumonia
-
Ente Ospedaliero Cantonale, BellinzonaCompleted
Clinical Trials on Toothbrushing + Chlorhexidine
-
Virginia Commonwealth UniversityNational Institute of Nursing Research (NINR)Completed
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedVentilator Associated Pneumonia
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedTracheal and Oropharyngeal Colonization by Gram-negative Pathogens
-
Riyadh Elm UniversityNot yet recruitingGingivitis | Dental PlaqueSaudi Arabia
-
University Hospital, Clermont-FerrandCompletedCritical Care | Mechanical Ventilation | Toothbrushing | Ventilator Associated Pneumonia Prevention | Oral CareFrance
-
Hospital Universitari Joan XXIII de Tarragona.UnknownPneumonia | Nosocomial Pneumonia | Ventilator-Associated PneumoniaSpain
-
University Hospital Schleswig-HolsteinProcter and GambleCompletedGingival Recession
-
University of GlasgowMinistry of Health, Saudi ArabiaCompleted
-
Ataturk UniversityCompleted
-
King's College LondonMinistry of Health, Saudi ArabiaRecruitingDental Caries in ChildrenSaudi Arabia